mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study of 128 patients

Head and Neck

Volumn 26, Issue 3, 2004, Pages 232-240

  D'Cruz, Anil K ^a   Robinson, Martin H ^b   Biel, Merrill A ^c  

^a TATA MEMORIAL HOSPITAL   (India)

^b WESTON PARK HOSPITAL   (United Kingdom)

^c Ear Nose and Throat Specialty Care of Minnesota   (United States)

Author keywords

MTHPC; Photodynamic therapy; Squamous cell carcinoma of the head and neck

Indexed keywords

TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; EVALUATION; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MESOPORPHYRINS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 1442300736     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10372     Document Type: Article

References (20)

1. Ferley J, Bray F, Sankila R, Parkin DM. EUCAN: Cancer Incidence, Mortality and Prevalence in the European Union 1997, version 4.1. IARC CancerBase No. 4. Lyon, IARC Press, 1999. Limited version available from: http://www.dep.iarc.fr/eucan/eucan.htm. Last updated on 18 November 2002.
2. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, CA Cancer J Clin 1994;44:7-26.
3. Galante E, Gallus G, Chiesa F, Bono A, Bettoni I, Molinari R. Growth rate of head and neck tumors. Eur J Cancer Clin Oncol 1982;18:707-712.
4. Steel GG. The growth rate of tumours. In: Steel G, editor. Basic clinical radiobiology, 2nd ed. London: Arnold; 1997. p 9-13.
5. Kramer S, Marcial VA, Pajak TF, MacLean CJ, Davis LW. Prognostic factors for loco/regional control and metastasis and the impact on survival. Int J Radiat Oncol Biol Phys 1986;12:573-578.
6. Wheeler RH. Chemotherapy of patients with recurrent head and neck cancer. In: Jacobs C, editor. Carcinomas of the head and neck: Evaluation and management. Boston: Kluwer Academic Publishers; 1990. p 171-193.
7. Dilkes MG, Alusi G, Djaezeri BJ. The treatment of head and neck cancer with photodynamic therapy: Clinical experience. Rev Contemp Pharmacother 1999;10:47-57.
8. Johansen LV, Overgaard J, Overgaard M, Birkler N, Fisker A. Squamous cell carcinoma of the oropharynx: An analysis of 213 consecutive patients scheduled for primary radiotherapy. Laryngoscope 1990;100:985-990.
9. Munro AJ, Sebag-Montefiore D. Opportunity cost-a neglected aspect of cancer treatment. Br J Cancer 1992;65:309-310.
10. Dougherty TJ, Marcus SL. Photodynamic therapy. Eur J Cancer 1992;28A:1734-1742.
11. Fisher AM, Murphree AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med 1995;17:2-31.
12. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: WHO; 1999. p 23-24.
13. Hassan SJ, Weymuller EA Jr. Assessment of quality of life in head and neck cancer patients. Head Neck 1993;15:485-496.
14. Carvalho AL, Salvajoli JV, Kowalski LP. A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas. Eur Arch Otorhinolaryngol 2000;257:164-167.
15. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001;345:1890-1900.
16. Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 1992;10:1245-1251.
17. Bensadoun RJ, Magne N, Marcy PY, Demard F. Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: New trends in pathophysiology, prevention and treatment. Eur Arch Otorhinolaryngol 2001;258:481-487.
18. Byar DP, Schoenfeld DA, Green SB, et al. Design considerations for AIDS trials. N Engl J Med 1990;323:1343-1348.
19. Ferley J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, version 1.0. IARC Cancer Base No. 5. Lyon, IARC Press, 2001. Limited version available from: http://www. dep.iarc.fr/globocan/globocan.htm Last updated on 3 February 2001.
20. Bonnett R. Photodynamic therapy in historical perspective. Rev Contemp Pharmacother 1999;10:1-17.